Mammary Paget's disease and extra-mammary Paget's disease: Two morphologically similar but biologically different diseases

Journal of Cutaneous Pathology

Volumn 37, Issue 11, 2010, Pages 1145-1149

  Liu, Weiguo ^a   Iqbal, Jabad ^b   Khoury, Thaer ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HER2 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; PATHOLOGY; PHOSPHORYLATION;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PAGET DISEASE, EXTRAMAMMARY; PAGET'S DISEASE, MAMMARY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 77956795186     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01403.x     Document Type: Article

References (19)

1. Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000 53 : 742.
2. Tavassoli FA, Devilee P. Pathology and genetics. Tumours of the breast and female genital organs. Albany, NY : WHO Publications Centre, 2003.
3. Olson DJ, Fujimura M, Swanson P. Immunohistochemical features of Paget's disease of the vulva with and without adenocarcinoma. Int J Gynecol Pathol 1991 10 : 285.
4. Sallmon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of HER-2/neu oncogene. Science 1987 235 : 177.
5. Seshardi R, Firgaira FA, Horsfall DJ, et al. Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. J Clin Oncol 1993 11 : 1936.
6. McCann AH, Dervan PA, O'Regan M, et al. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. Cancer Res 1991 51 : 3296.
7. Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC. Molecular markers in Paget disease of the breast. J Surg Oncol 2001 77 : 171.
8. Haerslev T, Krag JG. Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple. An immunohistochemical study. APMIS 1992 100 : 1041.
9. Meissner K, Riviere A, Haupt G, et al. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol 1990 137 : 1305.
10. Wolber RA, Bupuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease. Am J Clin Pathol 1991 96 : 243.
11. Keatings L, Sinclair J, Wright C, et al. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology 1990 17 : 243.
12. Nishi M, Yoshida H, Setoyama M, Tashiro M. Immunohistochemical study of c-erbB-2 oncoprotein expression in extramammary Paget's disease. Dermatology 1994 188 : 100.
13. Ogawa T, Nagashima Y, Wada H, et al. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein. Hum Pathol 2005 36 : 1273.
14. Chadha KS, Khoury T, Yu J, et al. Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma. Ann Surg Oncol 2006 13 : 933.
15. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007 131 : 18.
16. Liegl B, Leibl S, Gogg-Kamerer M, Tessaro B, Horn L-C, Moinfar F. Mammary and extramammary Paget's disease: an immunohistochemical study of 83 cases. Histopathology 2007 50 : 439.
17. Chen SY, Moroi Y, Urabe K, et al. Concordant overexpression of p-FAK and p-ERK1/2 in extramammary Paget's disease. Arch Dermatol Res 2008 300 : 195.
18. Liu HJ, Moroi Y, Masuda T, et al. Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease. Br J Dermatol 2006 154 : 926.
19. Liu H, Moroi Y, Yasumoto S, et al. Expression of insulin-like growth factor-1 receptor, p-AKT and p-ERK1/2 protein in extramammary Paget's disease. Br J Dermatol 2006 155 : 586.